
Results
2
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
2 companies
Pharma Mar
Market Cap: €1.3b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, China, Germany, Ireland, France, rest of the European Union, the United States, and internationally.
PHM
€75.25
7D
-0.5%
1Y
-3.6%
Oryzon Genomics
Market Cap: €264.2m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system) disorders.
ORY
€3.35
7D
13.0%
1Y
117.3%